FI95912C - Menetelmä terapeuttisesti aktiivisten pyrido/2,3-f//1,4/tiatsepiini- ja pyrido/3,2-b//1,5/bentsotiatsepiinijohdannaisten valmistamiseksi - Google Patents

Menetelmä terapeuttisesti aktiivisten pyrido/2,3-f//1,4/tiatsepiini- ja pyrido/3,2-b//1,5/bentsotiatsepiinijohdannaisten valmistamiseksi

Info

Publication number
FI95912C
FI95912C FI912124A FI912124A FI95912C FI 95912 C FI95912 C FI 95912C FI 912124 A FI912124 A FI 912124A FI 912124 A FI912124 A FI 912124A FI 95912 C FI95912 C FI 95912C
Authority
FI
Finland
Prior art keywords
pyrido
thiazepine
preparation
therapeutically active
benzothiazepine derivatives
Prior art date
Application number
FI912124A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI912124A7 (fi
FI912124A0 (fi
FI95912B (fi
Inventor
David J Wustrow
John H Dodd
Charles F Schwender
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of FI912124A0 publication Critical patent/FI912124A0/fi
Publication of FI912124A7 publication Critical patent/FI912124A7/fi
Application granted granted Critical
Publication of FI95912B publication Critical patent/FI95912B/fi
Publication of FI95912C publication Critical patent/FI95912C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Luminescent Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI912124A 1990-05-03 1991-05-02 Menetelmä terapeuttisesti aktiivisten pyrido/2,3-f//1,4/tiatsepiini- ja pyrido/3,2-b//1,5/bentsotiatsepiinijohdannaisten valmistamiseksi FI95912C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51835190 1990-05-03
US07/518,351 US5075440A (en) 1990-05-03 1990-05-03 Novel pyrido[2,3-f](1,4)thiazepines and pyrido[3,2-b](1,5)benzothiazepines

Publications (4)

Publication Number Publication Date
FI912124A0 FI912124A0 (fi) 1991-05-02
FI912124A7 FI912124A7 (fi) 1991-11-04
FI95912B FI95912B (fi) 1995-12-29
FI95912C true FI95912C (fi) 1996-04-10

Family

ID=24063558

Family Applications (1)

Application Number Title Priority Date Filing Date
FI912124A FI95912C (fi) 1990-05-03 1991-05-02 Menetelmä terapeuttisesti aktiivisten pyrido/2,3-f//1,4/tiatsepiini- ja pyrido/3,2-b//1,5/bentsotiatsepiinijohdannaisten valmistamiseksi

Country Status (25)

Country Link
US (1) US5075440A (https=)
EP (1) EP0462696B1 (https=)
JP (1) JP3296499B2 (https=)
KR (1) KR100195345B1 (https=)
CN (2) CN1034077C (https=)
AT (1) ATE126231T1 (https=)
AU (1) AU651580B2 (https=)
CA (1) CA2041594C (https=)
DE (1) DE69111915T2 (https=)
DK (1) DK0462696T3 (https=)
ES (1) ES2079570T3 (https=)
FI (1) FI95912C (https=)
GR (1) GR3017305T3 (https=)
HK (1) HK51496A (https=)
HU (1) HU218909B (https=)
IE (1) IE68524B1 (https=)
IL (6) IL127047A0 (https=)
MY (1) MY106552A (https=)
NO (1) NO179411C (https=)
NZ (1) NZ237988A (https=)
PT (1) PT97547B (https=)
TN (1) TNSN91030A1 (https=)
TW (1) TW218878B (https=)
ZA (1) ZA913319B (https=)
ZW (1) ZW5291A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6593335B1 (en) 1997-12-18 2003-07-15 Abbott Laboratories Potassium channel openers
US6265417B1 (en) 1997-12-18 2001-07-24 Abbott Laboratories Potassium channel openers
AU756505B2 (en) * 1997-12-18 2003-01-16 Abbott Laboratories Potassium channel openers
JPH11193289A (ja) * 1997-12-26 1999-07-21 Suntory Ltd ピロールスルホンアミド誘導体
US6482854B1 (en) * 1999-03-25 2002-11-19 Massachusetts Eye And Ear Infirmary Glaucoma treatment
US7015212B1 (en) 1999-05-12 2006-03-21 The United States Of America As Represented By The Department Of Health And Human Services Thiazepine inhibitors of HIV-1 integrase
HUP0201566A3 (en) * 1999-06-14 2004-03-01 Ortho Mcneil Pharm Inc Dithiepino[6,5-b]pyridines, their preparation pharmaceutical compositions containing thereof and an apparatus for their administering
ES2246248T3 (es) * 1999-07-12 2006-02-16 Ortho-Mcneil Pharmaceutical, Inc. Oxatiepino (6,5-b)dihidropiridinas, y composiciones y metodos relacionados.
US6472530B1 (en) 1999-09-22 2002-10-29 Ortho-Mcneil Pharmaceutical, Inc. Benzo-fused dithiepino[6,5-b]pyridines, and related compositions and methods
CA2396962A1 (en) 2000-01-12 2001-07-19 Ortho-Mcneil Pharmaceutical, Inc. Benzosulfones and related compositions and methods
AU783503B2 (en) * 2000-01-27 2005-11-03 Ortho-Mcneil Pharmaceutical, Inc. Benzoxathiepino(3,4-b)pyridine derivatives, process for their preparation and their use as medicaments
JP2003528104A (ja) 2000-03-23 2003-09-24 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド チエピノ［３，２−ｂ］ジヒドロピリジンおよび関連組成物ならびに方法
CN1444587A (zh) 2000-05-30 2003-09-24 奥索-麦克尼尔药品公司 二氢吡啶软药及相关组合物和方法
KR101233139B1 (ko) 2011-04-21 2013-02-21 주식회사 한서켐 라세믹 1,4-티아제핀 화합물의 분할 방법
US20160207893A1 (en) * 2014-12-30 2016-07-21 Myotherix, Inc. Novel calcium modulators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1587128A (en) * 1977-04-07 1981-04-01 Hexachimie Benzothiazepine derivatives
US4285955A (en) * 1978-10-31 1981-08-25 Bayer Aktiengesellschaft 1,4-Dihydropyridinecarboxylic acids
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
FR2511683A1 (fr) * 1981-08-20 1983-02-25 Hexachimie Nouveaux derives de la pyrido (2,3-b) benzothiazepine(1,5) substituee en 5 par une carboxypiperazine, leur procede de preparation, leur application en therapeutique
EP0225175A3 (en) * 1985-11-28 1988-12-28 FISONS plc Dihydropyridine derivatives, processes for their preparation and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
CA2041594A1 (en) 1991-11-04
IE68524B1 (en) 1996-06-26
IL120446A0 (en) 1997-07-13
HU911476D0 (en) 1991-11-28
KR910020019A (ko) 1991-12-19
TNSN91030A1 (fr) 1992-10-25
KR100195345B1 (ko) 1999-06-15
JPH04225986A (ja) 1992-08-14
ATE126231T1 (de) 1995-08-15
IE911488A1 (en) 1991-11-06
HU218909B (hu) 2000-12-28
IL120446A (en) 2000-08-31
IL127047A0 (en) 1999-09-22
HK51496A (en) 1996-03-29
IL127047A (en) 2000-10-31
PT97547A (pt) 1992-01-31
AU651580B2 (en) 1994-07-28
CN1056880A (zh) 1991-12-11
MY106552A (en) 1995-06-30
FI912124A7 (fi) 1991-11-04
IL97999A0 (en) 1992-06-21
FI912124A0 (fi) 1991-05-02
CN1034077C (zh) 1997-02-19
EP0462696B1 (en) 1995-08-09
ZW5291A1 (en) 1993-01-06
NO179411B (no) 1996-06-24
CN1039416C (zh) 1998-08-05
CA2041594C (en) 2002-07-23
AU7635491A (en) 1991-11-07
GR3017305T3 (en) 1995-12-31
ES2079570T3 (es) 1996-01-16
HUT60745A (en) 1992-10-28
IL120447A (en) 1999-12-22
IL97999A (en) 1997-06-10
TW218878B (https=) 1994-01-11
NO179411C (no) 1996-10-02
EP0462696A1 (en) 1991-12-27
DE69111915T2 (de) 1996-01-04
CN1118783A (zh) 1996-03-20
NO911723L (no) 1991-11-04
DK0462696T3 (da) 1995-09-18
JP3296499B2 (ja) 2002-07-02
PT97547B (pt) 1998-08-31
US5075440A (en) 1991-12-24
NZ237988A (en) 1992-09-25
ZA913319B (en) 1993-01-27
NO911723D0 (no) 1991-05-02
FI95912B (fi) 1995-12-29
DE69111915D1 (de) 1995-09-14
IL120447A0 (en) 1997-07-13

Similar Documents

Publication Publication Date Title
FI95912C (fi) Menetelmä terapeuttisesti aktiivisten pyrido/2,3-f//1,4/tiatsepiini- ja pyrido/3,2-b//1,5/bentsotiatsepiinijohdannaisten valmistamiseksi
FI943363A7 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten /1,4/oksatsino/3,4-a//2/bentsatsepiinijohdannaisten valmistamiseksi
FI862643A7 (fi) Menetelmä terapeuttisesti aktiivisen S(-)-9-halogeeni-3-alkyyli-10-(4-alkyylipiperatsinyyli)-7-okso-2,3-dihydro-7H-pyrido/1,2,3-de//1,4/bentsoksatsiini-6-karboksyylihapon valmistamiseksi
FI891910A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten pyrido/1,2,3-de//1,4/bentsoksatsiinijohdannaisten valmistamiseksi
FI92828C (fi) Menetelmä valmistaa terapeuttisesti arvokasta 5,11-dihydro-6H-dipyrido/3,2-b:2',3'-e/ /1,4/diatsepin-6-onia
FI905788L (fi) Menetelmä terapeuttisesti käyttökelpoisten 6-aryyli-5,6-dihydroimidatso/2,1-b/tiatsolijohdannaisten valmistamiseksi
FI93454B (fi) Menetelmä terapeuttisesti aktiivisten tiasykloalkeno/3,2-b/pyridiinien valmistamiseksi
HUT45072A (en) Process for producing 2-substituted-4-deoxy-thiazolo /5,4-c/rifamycin-sv-derivatives and pharmaceutically acceptable acid-addition salts thereof
FI912247A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten pyrrolo/2,3-b/indoliketonijohdannaisten valmistamiseksi
NZ235080A (en) Pyrido(2,3-b)(1,5)benz(ox- or thi-)azepinones and pharmaceutical compositions thereof
FI914681A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten N-alkenyylibentso/b/tieno-/3,2-b/oksatsiini-2,4-dionien valmistamiseksi
FI892181A7 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten pyrrolo-/1,2-a/atsepinonijohdannaisten valmistamiseksi
FI891954A0 (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten heksahydro-8-hydroksi-2,6-metano-2H-kinolitsin-3(4H)-onin esterijohdannaisten valmistamiseksi
FI904244A0 (fi) Menetelmä valmistaa terapeuttisesti tehokkaita pyrido-/2,3-b//1,5/bentsoksatsepin- ja tiatsepin-5-(6H)oneja
LV5737A4 (lv) Tetrahidro-1H-piridoÚ4,3-b¾indol-1-ona atvasinajumi
FI925310A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 4-okso-4,5-dihydro-imidatso/1,5-a/pyrido/2,3-e/pyratsiinijohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
BB Publication of examined application